Status:

WITHDRAWN

The Effect of Perioperative Pregabalin on the Incidence of Chronic Post-thoracotomy Pain Syndrome

Lead Sponsor:

Queen's University

Collaborating Sponsors:

McMaster University

Conditions:

Chronic Pain

Eligibility:

All Genders

18-75 years

Phase:

PHASE3

Brief Summary

Pregabalin, administered prior to and following lateral thoracotomy surgery will reduce the likelihood of chronic post-thoracotomy pain syndrome (CPTPS).

Detailed Description

A total of 200 patients scheduled for lateral thoracotomy will be randomly assigned to receive either placebo or 150 mg pregabalin (Lyrica)1 hour prior to surgery, 12 hr after surgery and then every 1...

Eligibility Criteria

Inclusion

  • Elective open thoracotomy for primary thoracic surgery, understanding and provision of written informed consent, ASA class I II or III

Exclusion

  • Inability ot adhere to study protocol:
  • intolerance or hypersensitivity to any agents to be used in the study, contraindication to thoracic epidural placement
  • inability to respond to the study questionnaire
  • renal insufficiency(serum creatinine \> 1.5 upper limit of normal)
  • Body Mass index \> 40
  • planned post-operative ventilation.
  • Confounding procedural factors which might affect validity of data:
  • previous ipsilateral thoracotomy
  • surgery for tumor extending into the chest wall
  • rest pain in proposed surgical area pre-operatively
  • chest tube in situ at time of surgery
  • requirement for second thoracotomy or re-occurrence of disease after surgery \*isolated pleuroscopy or pleurodesis procedures.
  • Potential interaction with study medications and patient's current medications:
  • current alcohol or other substance abuse
  • chronic steroid use
  • pre-existing chronic pain requiring chronic analgesic use
  • history of seizure disorder requiring treatment with an anticonvulsant
  • current therapy with thiazolidinedione class oral hypoglycemic agents (eg, Actos, Avandia or Avandamet)
  • history of congestive heart failure
  • major psychiatric disorder
  • any contraindication to use of NSAIDs.
  • Insufficient safety data in the patient population:
  • patients requiring preoperative assistance or assistive device for ambulation, pregnant or breastfeeding
  • weight \<50 Kg
  • dizziness while inpatient.

Key Trial Info

Start Date :

May 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2014

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00998816

Start Date

May 1 2012

End Date

October 1 2014

Last Update

April 11 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Dr. Jorge E Zamora

Kingston, Ontario, Canada, K7L 2V7